Isoprenaline hydrochloride是非选择性的β-肾上腺素受体激动剂,与肾上腺素相似。
Isoprenaline is a non-selective beta-adrenergic receptor agonist, used for the treatment of bradycardia and heart block. Isoproterenol hydrochloride is a phenethylamine derivative and selective β-AR adrenergic agonist shown to increase cytosolic cAMP. Exhibits promotion of glycogen breakdown and causes bronchodilation and vasorelaxant effects. Also potentially stimulates relaxation in nitric oxide mediated endothelium-dependent smooth muscle. Isoproterenol Hydrochloride is an activator of β2-AR and ERK.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Degerman E, et al. Proc Natl Acad Sci U S A, 1990, 87(2), 533-537.
[2] Ladenheim, R.G., et al. 1993. J. Neurochem. 60: 260-266.
[3] Macaulay, S.L., et al. 1994. Mol. Cell Biochem. 141: 27-33.
[4] Kishimoto, I., et al. 1994. J. Biol. Chem. 269: 28300-28308.
[5] Takemura, H., et al. 1995. J. Pharmacol. Exp. Ther. 274: 584-588.
[6] Schmitt, J.M. and Stork, P.J. 2000. J. Biol. Chem. 275: 25342-25350.
分子式 C11H18ClNO3 |
分子量 247.72 |
CAS号 51-30-9 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 50 mg/mL |
Water 50 mg/mL |
Ethanol 20 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT01377636 | Intraoperative Awareness | Drug: Isoproterenol | New York University School of Medicine | 2009-08-01 | 2015-02-17 | |
NCT00226551 | Coronary Disease | Drug: Isoproterenol | Hadassah Medical Organization | 1999-08-01 | 2008-10-28 | |
NCT00624416 | Lipoma | Drug: Prednisolone synthetic cortisone and Isoproterenol together | Pennington Biomedical Research Center|Lipothera | Phase 1|Phase 2 | 2007-10-01 | 2015-12-17 |
NCT03019081 | Anorexia Nervosa | Drug: Isoproterenol|Other: placebo | Laureate Institute for Brain Research, Inc.|Brain & Behavior Research Foundation | 2017-01-01 | 2017-01-10 | |
NCT03032965 | Atrial Fibrillation | Drug: Adenosine|Drug: Isoproterenol | University of Michigan | Phase 2 | 2011-10-01 | 2017-01-23 |
NCT00083395 | Arrhythmic Right Ventricular Cardiomyopathy | National Institutes of Health Clinical Center (CC) | 2004-05-01 | 2008-03-03 | ||
NCT02673996 | Postural Tachycardia Syndrome | Drug: Phenylephrine|Drug: Isoproterenol | University of Calgary | 2016-01-01 | 2016-08-15 | |
NCT02615119 | Major Depressive Disorder|Anorexia Nervosa|Generalized Anxiety Disorder|Panic Disorder|Brain Injury | Drug: Isoproterenol|Drug: Normal saline | Laureate Institute for Brain Research, Inc. | 2015-10-01 | 2017-02-02 | |
NCT02286934 | Healthy | Drug: Carvedilol|Other: Isoproterenol Sensitivity Test | Seoul National University Hospital|National Institute of Food and Drug Safety Evaluation, Korea | Phase 1 | 2014-09-01 | 2015-06-02 |
NCT00428428 | Kidney Stone|Unexplained Haematuria|Benignant Tumour Mass in the Upper Urinary Tract | Drug: Isoproterenol | Fredericia Hosptial | Phase 2|Phase 3 | 2007-02-01 | 2007-11-15 |
NCT00323843 | Kidney Stone|Ureteroscopy | Drug: Isoproterenol | Fredericia Hosptial | Phase 2 | 2006-06-01 | 2007-01-29 |
NCT02725060 | Postural Orthostatic Tachycardia Syndrome|Postural Tachycardia Syndrome|Tachycardia|Arrhythmias, Cardiac|Autonomic Nervous System Diseases|Orthostatic Intolerance|Cardiovascular Diseases|Primary Dysautonomias | Drug: phenylephrine|Drug: isoproterenol|Radiation: 25 micro-Ci of radiation|Procedure: Posture study with blood samples|Procedure: 24-hour heart rhythm and blood pressure monitoring|Procedure: Quantitative Axonal Sudomotor Reflex Testing|Procedure: Autonomic function tests | Vanderbilt University|University of Oklahoma | 2016-02-01 | 2016-10-14 | |
NCT02524145 | Heart Failure | Other: Static Handgrip|Drug: Dexmedetomidine|Drug: Glycopyrrolate|Drug: Isoproterenol | University of Texas Southwestern Medical Center | 2013-03-01 | 2016-05-10 | |
NCT01708655 | Cystic Fibrosis | Other: Sweat Evaporimeter measurement | University of Colorado, Denver|Cystic Fibrosis Foundation Therapeutics | 2011-12-01 | 2014-12-01 | |
NCT01538277 | Atrial Fibrillation|Burden of Atrial Fibrillation | Procedure: Contact Force during ablation|Other: Standard ablation procedure | University of Aarhus | Phase 2 | 2012-02-01 | 2016-10-27 |
NCT02586883 | Idiopathic Dilation of the Bronchi | Other: bronchial ddp test | Assistance Publique - H么pitaux de Paris | 2016-04-01 | 2016-12-02 | |
NCT00945347 | Cystic Fibrosis | Drug: Miglustat|Drug: Placebo | Cliniques universitaires Saint-Luc- Universit茅 Catholique de Louvain | Phase 2 | 2009-07-01 | 2011-08-09 |
NCT01002534 | Cystic Fibrosis | Drug: Vardenafil|Drug: Placebo | Cliniques universitaires Saint-Luc- Universit茅 Catholique de Louvain | Phase 2 | 2011-10-01 | 2012-06-06 |
NCT00782782 | Congestive Heart Failure | Hadassah Medical Organization | 2008-08-01 | 2008-10-28 | ||
NCT00537602 | Cystic Fibrosis | Drug: miglustat|Drug: placebo | Actelion | Phase 2 | 2007-11-01 | 2010-02-11 |
NCT00742092 | Cystic Fibrosis | Drug: miglustat|Drug: placebo | Actelion | Phase 2 | 2008-08-01 | 2014-03-05 |
NCT01079715 | Retinopathy of Prematurity | Drug: Propranolol | Azienda Ospedaliero, Universitaria Meyer|Ospedale Maggiore Policlinico Mangiagalli e Regina Elena | Phase 2|Phase 3 | 2010-01-01 | 2012-11-24 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们